Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Treasury Shares: 2017-2022

Historic Treasury Shares for Dianthus Therapeutics (DNTH) over the last 4 years, with Dec 2022 value amounting to $16,084.

  • Dianthus Therapeutics' Treasury Shares was N/A to $63 in Q3 2023 from the same period last year, while for Sep 2023 it was $63, marking a year-over-year change of. This contributed to the annual value of $16,084 for FY2022, which is N/A change from last year.
  • Latest data reveals that Dianthus Therapeutics reported Treasury Shares of $16,084 as of FY2022, which was down 92.18% from $205,722 recorded in FY2019.
  • In the past 5 years, Dianthus Therapeutics' Treasury Shares ranged from a high of $1.0 million in FY2018 and a low of $16,084 during FY2022.
  • For the 1-year period, Dianthus Therapeutics' Treasury Shares averaged around $16,084, with its median value being $16,084 (2022).
  • Data for Dianthus Therapeutics' Treasury Shares shows a maximum YoY tumbled of 79.88% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Dianthus Therapeutics' Treasury Shares stood at $1.0 million in 2018, then slumped by 79.88% to $205,722 in 2019, then reached $16,084 in 2022.